Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour.
about
Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine.Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.Langerhans cells as targets for immunotherapy against skin cancer.Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD)Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression.Microneedles for drug and vaccine deliveryPocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin.Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-conceptSkin permeabilization for transdermal drug delivery: recent advances and future prospects.Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet.
P2860
Q30391402-A19EE0C7-4D54-4D94-AD15-D052862CDA2EQ33563977-61A516F1-6055-4B7F-BE71-8B5CB3732C49Q33682225-0B2AFDC5-D747-4FAD-9D3B-CCDC03732375Q34009436-48D94223-F523-484B-89CD-8B28ECD67B86Q34209790-0CBF013F-26F6-437B-B9EF-33B13A4D3F6EQ36020905-24CEF4C1-D1B7-4717-B6AC-EA4B1645F13EQ36077060-3E61AEC9-D6F2-406E-9EB2-CA50423973E6Q36164749-5F5BEBC1-24F1-493B-81C7-E4819E4A3A1DQ36525754-384DCD6D-A488-4798-B2DD-9DD99664A342Q36674114-581FDEC0-6A49-4581-B4CA-AB35C0ED2681Q38176047-39B2B1FE-9186-4149-ADC3-0B7AB8E96964Q44542292-B450151A-79C1-468D-AACE-046F5E10994C
P2860
Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of an ex vivo huma ...... and Langerhans cell behaviour.
@en
Development of an ex vivo huma ...... and Langerhans cell behaviour.
@nl
type
label
Development of an ex vivo huma ...... and Langerhans cell behaviour.
@en
Development of an ex vivo huma ...... and Langerhans cell behaviour.
@nl
prefLabel
Development of an ex vivo huma ...... and Langerhans cell behaviour.
@en
Development of an ex vivo huma ...... and Langerhans cell behaviour.
@nl
P2093
P2860
P50
P1433
P1476
Development of an ex vivo huma ...... and Langerhans cell behaviour
@en
P2093
Alexander Anstey
Anthony Morrissey
Christopher Gateley
Marc Pearton
P2860
P304
P356
10.1016/J.VACCINE.2009.07.088
P407
P577
2009-08-11T00:00:00Z